Last reviewed · How we verify

NCT04377685: COVID-CTPRED

Prediction of Clinical Course in COVID19 Patients

Completed Last updated 17 November 2021
What this trial tests

trial testing CT-Scan in COVID 19 in 826 participants. Completed in 26 December 2020.

Timeline
1 March 2020
Primary endpoint
28 November 2020
26 December 2020

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Saint Etienne
StatusCompleted
Study typeOBSERVATIONAL
Enrollment826
Start date1 March 2020
Primary completion28 November 2020
Estimated completion26 December 2020
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Who can join

18 and older, any sex, with COVID 19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the context of the COVID19 pandemic and containment, chest CT is currently frequently performed on admission, looking for suggestive signs and basic abnormalities of COVID19 compatible viral pneumonitis pending confirmation of identification of viral RNA by reverse-transcription polymerase chain reaction(PCR), with a reported sensitivity of 56-88% in the first few days, slightly higher than PCR (60%) (1). Nevertheless, currently established radiological abnormalities are not specific for COVID19 and the specificity of the chest CT is \~25% when PCR is used as a reference (1). Deconfinement and its consequences will complicate the triage of COVID patients and the role of the scanner, with the expected impact of a decrease in the prevalence of infection in the emergency department and an increase in the number of "all-round" patients, including patients with non-COVID viral infiltrates or pneumopathies. In addition, there are currently no imaging criteria to complement the clinical and biological data that can predict the progression of lung disease from the initial data.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Imaging in the COVID-19 era: Lessons learned during a pandemic.
    Sideris GA, Nikolakea M, Karanikola AE, Konstantinopoulou S, et al · · 2021 · cited 7× · PMID 34249239 · DOI 10.4329/wjr.v13.i6.192

Verify or expand the search:

Other trials of CT-Scan

Trials testing the same drug.

Other recruiting trials for COVID 19

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de Saint Etienne trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04377685.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing